Shanton Pharma USA Inc.
- Biotech or pharma, therapeutic R&D
Shanton Pharma is developing a unique oral Urate Lowering Therapy for Refractory / Tophaceous Gout, based on novel MOA. Our lead program is Phase 3-ready and available for global partnering.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}